Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 2
2003 4
2004 4
2005 2
2008 2
2009 4
2012 2
2013 3
2014 5
2015 3
2016 6
2017 6
2018 4
2019 3
2020 7
2021 7
2022 4
2023 7
2024 11
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Spicer JD, Garassino MC, Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Arunachalam A, Keller SM, Samkari A, Gao S; KEYNOTE-671 Investigators. Spicer JD, et al. Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288781 Free PMC article. Clinical Trial.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Free PMC article. Clinical Trial.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.
Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis.
Nuccio A, Salomone F, Servetto A, Ricciuti B, Marinelli D, Bulotta A, Veronesi G, Garassino MC, Torri V, Besse B, Viscardi G, Ferrara R. Nuccio A, et al. Among authors: bulotta a. J Natl Cancer Inst. 2025 Nov 1;117(11):2388-2393. doi: 10.1093/jnci/djaf090. J Natl Cancer Inst. 2025. PMID: 40210599
Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study.
Paolino G, Tosti G, Mascagni D, Di Nicola MR, Valenti M, Ardigò M, Cantisani C, Podo Brunetti A, Eberspacher C, Giacomelli L, Russo V, Melcarne R, Mistrangelo M, Quaglino P, Senetta R, Picciariello A, Vincenti L, Rega D, Delrio P, Caracò C, Portinaio M, Damiano G, Bulotta A, Rizzo N, Arcieri S, Rongioletti F, Carugno A, Di Ciaccio SM, Falcone R, Ricci F, Pampena R, Mercuri SR. Paolino G, et al. Among authors: bulotta a. J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e791-e795. doi: 10.1111/jdv.20647. Epub 2025 Mar 18. J Eur Acad Dermatol Venereol. 2025. PMID: 40103352 No abstract available.
Feasibility of a Standardized Management for Primary Spontaneous Pneumothorax in Children and Adolescents: A Retrospective Multicenter Study and Review of the Literature.
Cerchia E, Conighi ML, Bleve C, Chiarenza SF, Sgrò A, Pini Prato A, Rotundi F, Parolini F, Bulotta AL, Alberti D, Rena O, Rapuzzi G, Rossi F, La Canna F, Cheli M. Cerchia E, et al. Among authors: bulotta al. J Laparoendosc Adv Surg Tech A. 2020 Jul;30(7):841-846. doi: 10.1089/lap.2019.0493. Epub 2020 Apr 27. J Laparoendosc Adv Surg Tech A. 2020. PMID: 32343922 Review.
Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors.
Gagliardi F, De Domenico P, Snider S, Roncelli F, Pompeo E, Barzaghi LR, Bulotta A, Gregorc V, Lazzari C, Cascinu S, Finocchiaro G, Mortini P. Gagliardi F, et al. Among authors: bulotta a. Crit Rev Oncol Hematol. 2021 Sep;165:103431. doi: 10.1016/j.critrevonc.2021.103431. Epub 2021 Jul 27. Crit Rev Oncol Hematol. 2021. PMID: 34324961
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis.
Oresti S, Salomone F, Nuccio A, Ogliari FR, Riva ST, Mollica L, Bulotta A, Viganò MG, Venanzi FM, Passaretti F, Papotto L, Di Lello A, Ferrara M, Foggetti G, Damiano G, Servetto A, Califano R, Di Maio M, Ricciuti B, Cortellini A, Reck M, Cinquini M, Torri V, Viscardi G, Ferrara R. Oresti S, et al. Among authors: bulotta a. EClinicalMedicine. 2025 Sep 2;88:103482. doi: 10.1016/j.eclinm.2025.103482. eCollection 2025 Oct. EClinicalMedicine. 2025. PMID: 40969680 Free PMC article.
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Venanzi FM, Bini M, Nuccio A, De Toma A, Lambertini M, Ogliari FR, Oresti S, Viganò MG, Brioschi E, Polignano M, Naldini MM, Riva S, Ferrara M, Fogale N, Damiano G, Russo V, Reni M, Veronesi G, Foggetti G, Conforti F, Bulotta A, Ferrara R. Venanzi FM, et al. Among authors: bulotta a. Cancer Treat Rev. 2023 Dec;121:102648. doi: 10.1016/j.ctrv.2023.102648. Epub 2023 Oct 26. Cancer Treat Rev. 2023. PMID: 37918169 Review.
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database.
Reale ML, Passiglia F, Cappuzzo F, Minuti G, Occhipinti M, Bulotta A, Delmonte A, Sini C, Galetta D, Roca E, Pelizzari G, Cortinovis D, Gariazzo E, Pilotto S, Citarella F, Bria E, Muscolino P, Pozzessere D, Carta A, Pignataro D, Calvetti L, Leone F, Banini M, Di Micco C, Baldini E, Favaretto A, Malapelle U, Novello S, Pasello G, Tiseo M. Reale ML, et al. Among authors: bulotta a. ESMO Open. 2024 Sep;9(9):103680. doi: 10.1016/j.esmoop.2024.103680. Epub 2024 Aug 29. ESMO Open. 2024. PMID: 39214048 Free PMC article.
93 results